This site is intended for healthcare professionals only
LoginRegister

Cardiology-CTVS Dialogues

Sacubitril/Valsartan Shows No Clinical Advantage over enalapril in HF due to Chagas disease: JAMA

Sacubitril/Valsartan Shows No Clinical Advantage over enalapril in HF due to Chagas disease: JAMA

According to a new study published in JAMA, sacubitril/valsartan did not demonstrate a significant difference in major clinical outcomes compared with...
View All

Latest News and Guidelines

Coronary Calcium Emerges as Key Risk Marker in Low CV Risk Patients, Latest AJPC December 2025 Study

Coronary Calcium Emerges as Key Risk Marker in Low CV Risk Patients, Latest AJPC December 2025 Study

Daytime Physical Activity Linked to Lower MAFLD Risk in Adolescents: AJPC Study, December 2025

Daytime Physical Activity Linked to Lower MAFLD Risk in Adolescents: AJPC Study, December 2025

Levosimendan Fails to Improve ECMO Weaning in Severe Cardiogenic Shock, LEVOECMO Trial Reports

Levosimendan Fails to Improve ECMO Weaning in Severe Cardiogenic Shock, LEVOECMO Trial Reports

AI-Assisted Screening May Enhance Detection of Transthyretin Myloid Cardiomyopathy: JAMA

AI-Assisted Screening May Enhance Detection of Transthyretin Myloid Cardiomyopathy: JAMA

Lower Baseline LDL Levels Linked to Higher Type 2 Diabetes Risk: Study

Lower Baseline LDL Levels Linked to Higher Type 2 Diabetes Risk: Study

Lifes Essential 8: A Potent Predictor for Short- and Long-Term Cardiovascular Risk, AJPC Study December 2025

Life's Essential 8: A Potent Predictor for Short- and Long-Term Cardiovascular Risk, AJPC Study...

View All
X